$3.87
+0 (+0%)
At Close: Oct 16, 2025
ProFound AI™ Risk Receives CE Mark in Europe
12:00pm, Wednesday, 15'th Jul 2020
First and only commercially available clinical decision support tool provides accurate two-year breast cancer risk estimation personalized for each woman iCAD unveils new.
SimonMed Imaging Accelerates Nationwide Deployment of iCAD’s ProFound AI™
12:00pm, Monday, 13'th Jul 2020
NASHUA, N.H. and PHOENIX, July 13, 2020 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, and.
NEW YORK, NY / ACCESSWIRE / July 2, 2020 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary du
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating iCAD, Inc. for Potential Breach of Fiduciary Duty Claims
09:10pm, Thursday, 02'nd Jul 2020
NEW YORK, NY / ACCESSWIRE / July 2, 2020 / Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of iCAD, Inc. (NASDAQ: ICAD ). If you
iCAD Inc (ICAD): Hedge Funds Sticking Around
08:56pm, Thursday, 02'nd Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Brachytherapy Devices Market Analysis Highlights the Impact of COVID-19, 2020-2024 | High Prevalence of Cancer to Augment Growth | Technavio
12:00am, Wednesday, 01'st Jul 2020
The Global Brachytherapy Devices Market will grow by USD 388.62 mn during 2020-2024
iCAD Added to Russell 2000® Index
01:42pm, Monday, 29'th Jun 2020
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. The annual Russell reconstitution captures the 4
United Capital Financial Advisers LLC Buys 28,332 Shares of iCAD Inc (NASDAQ:ICAD)
07:36am, Thursday, 25'th Jun 2020
United Capital Financial Advisers LLC increased its stake in iCAD Inc (NASDAQ:ICAD) by 54.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SE
iCAD To Host Jun. 4 Virtual Roundtable Event on Breast Cancer Surgery And Targeted Radiation During COVID-19
12:11pm, Monday, 01'st Jun 2020iCAD Hosts Virtual Roundtable Event on Breast Cancer Surgery and Targeted Radiation During COVID-19
12:00pm, Monday, 01'st Jun 2020
NASHUA, N.H., June 01, 2020 -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it.
News Flash: 5 Analysts Think iCAD, Inc. (NASDAQ:ICAD) Earnings Are Under Threat
01:59pm, Saturday, 16'th May 2020
One thing we could say about the analysts on iCAD, Inc. (NASDAQ:ICAD) - they aren't optimistic, having just made a...
iCAD Highlights Presentation Of New Clinical Data From Xoft Brain IORT At ASCO May 29-31
09:19pm, Wednesday, 13'th May 2020iCAD Presents Positive New Clinical Data for Xoft Brain IORT at American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
09:00pm, Wednesday, 13'th May 2020
Promising clinical research supports Xoft brain IORT as a viable treatment option for glioblastoma multiforme that may extend patients’ lives Overall survival benefit.
Edited Transcript of ICAD earnings conference call or presentation 11-May-20 8:30pm GMT
10:19pm, Tuesday, 12'th May 2020
Q1 2020 ICAD Inc Earnings Call
The
Sign In
Buy ICAD